LUNG
USDPulmonx Corporation Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$1.790
最高
$1.790
最低
$1.660
交易量
0.89M
公司基本面
市值
69.4M
行業
醫療器材
國家
United States
交易統計
平均交易量
2.37M
交易所
NMS
貨幣
USD
52週範圍
AI分析報告
最後更新: 2025年10月31日LUNG (Pulmonx Corporation) Market Analysis: Undervalued MedTech with Mixed Signals
Quick Overview
Pulmonx (LUNG) trades at $2.03 as of October 31, 2025, with a negative P/E ratio (-1.27) and small market cap ($82.6M). Recent analyst upgrades and a management shakeup dominate headlines, while technical indicators show caution. Fundamental scores suggest potential value, but debt and weak equity returns weigh down long-term confidence.
Key News Sentiment
- Analyst Optimism Amid Lower Targets
- Lake Street and D. Boral Capital kept "Buy" ratings but slashed price targets (from $8 → $4 and $16 → $14).
- Why it matters: Analysts see long
相關新聞
Lake Street Maintains Buy on Pulmonx, Lowers Price Target to $4
Lake Street analyst Frank Takkinen maintains Pulmonx with a Buy and lowers the price target from $8 to $4.
D. Boral Capital Maintains Buy on Pulmonx, Lowers Price Target to $14
D. Boral Capital analyst Jason Kolbert maintains Pulmonx with a Buy and lowers the price target from $16 to $14.
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial Officer, appointed
AI預測Beta
AI推薦
更新於: 2025年11月4日 下午06:55
61.4% 信心度
風險與交易
入場點
$1.81
獲利了結
$2.06
止損
$1.66
關鍵因素
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。